Novartis Pharmaceuticals
About
Novartis Pharmaceuticals, listed with the Central Square Business Improvement District, represents the Cambridge presence of Novartis, a leading global medicines company. The company uses innovative science and digital technologies to create treatments in areas of great medical need, with a stated purpose of reimagining medicine to improve and extend people’s lives. It aims to be a trusted leader in changing the practice of medicine, with a strategy built on advanced therapy platforms and data science.
The company marks 30 years as Novartis, formed in 1996 when Sandoz and Ciba-Geigy merged, and it describes a heritage of discovery stretching back 250 years to the chemical companies of Basel. Its history includes work on targeted therapy, which one employee recalls as a completely new way of tackling cancer. Recent work includes remibrutinib, now FDA-approved for symptomatic dermographism, and continued research in multiple sclerosis.
What to Know
- Novartis products reach more than 750 million people globally.
- The company ranks among the world’s top spenders on research and development.
- Novartis is headquartered in Basel, Switzerland.
- Expanding access to the latest treatments is a stated company priority.
Is this your business?
Claim it to add hours, photos, a description and a spotlight story.